Research Directory Details | National Medical Research Register

Cost Effectiveness Analysis of erythropoietin in the Ministry of Health (MOH) dialysis program

Cost Effectiveness Analysis of erythropoietin in the Ministry of Health (MOH) dialysis program

EPO CEA

General Information
Research Type
Clinical
Description
Anaemia is often prevalent among renal failure patients and as the cost of treatment is high, this warrants an economic analysis on the subject. The cost viewpoint taken here is that of MOH and the main outcome of interest is quality adjusted life years on dialysis for patients receiving erythropoietin (EPO)
Study Information
RMK Priority Area
Research Level
Research Keyword
cost effective analysis
cost per life years saved
Quality adjusted life years
erythropoietin
renal failure
dialysis
Inclusion & Exclusion Criteria
Inclusion Criteria
Nephrology medical professionals (nephrologists, nurses or medical assistants)
Patients receiving dialysis
Exclusion Criteria
Nephrology medical professionals (nephrologists, nurses or medical assistants)
Patients receiving dialysis
Study Timeline
Expected / Actual Date Study Starts - First Enrolment of subject / Collecting data
Nov, 30 2004
Expected / Actual Date Study Completed
Feb, 28 2006
Expected / Actual Duration of Study Enrollment / Data Collection
65 weeks